Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Capital Expenditures (2016 - 2025)

InspireMD's Capital Expenditures history spans 16 years, with the latest figure at $398000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 27.97% year-over-year to $398000.0; the TTM value through Dec 2025 reached $1.7 million, up 18.54%, while the annual FY2025 figure was $1.7 million, 18.54% up from the prior year.
  • Capital Expenditures reached $398000.0 in Q4 2025 per NSPR's latest filing, up from $329000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $576000.0 in Q2 2025 to a low of $25000.0 in Q1 2023.
  • Average Capital Expenditures over 5 years is $213100.0, with a median of $176000.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: tumbled 60.87% in 2023, then soared 955.56% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $107000.0 in 2021, then decreased by 11.21% to $95000.0 in 2022, then surged by 126.32% to $215000.0 in 2023, then surged by 44.65% to $311000.0 in 2024, then grew by 27.97% to $398000.0 in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Capital Expenditures are $398000.0 (Q4 2025), $329000.0 (Q3 2025), and $576000.0 (Q2 2025).